Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2310-2318
Published online before print August 23, 2007, doi: 10.1161/ATVBAHA.107.151407
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/11/2310    most recent
ATVBAHA.107.151407v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Weel, V.
Right arrow Articles by Quax, P.H.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Weel, V.
Right arrow Articles by Quax, P.H.A.
Related Collections
Right arrowRelated Article
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2310.)
© 2007 American Heart Association, Inc.


Vascular Biology

Natural Killer Cells and CD4+ T-Cells Modulate Collateral Artery Development

V. van Weel; R.E.M. Toes; L. Seghers; M.M.L. Deckers; M.R. de Vries; P.H. Eilers; J. Sipkens; A. Schepers; D. Eefting; V.W.M. van Hinsbergh; J.H. van Bockel; P.H.A. Quax

From the Gaubius Laboratory (V.v.W., L.S., M.M.L.D., M.R.d.V., J.S., A.S., D.E., P.H.A.Q.), TNO Quality of Life, Leiden, the Netherlands; and the Departments Surgery (V.v.W., A.S., D.E., J.H.v.B., P.H.A.Q.), Rheumatology (R.E.M.T.), and Medical Statistics (P.H.E.), Leiden University Medical Center (LUMC), Leiden, the Netherlands, and Laboratory for Physiology, ICAR-VU, VU University Medical Center, Amsterdam, the Netherlands (L.S., V.W.M.v.H.).

Correspondence to Dr P.H.A. Quax, TNO-QOL, P.O. Box 2215, 2301CE Leiden, the Netherlands. E-mail paul.quax{at}tno.nl

Objective— The immune system is thought to play a crucial role in regulating collateral circulation (arteriogenesis), a vital compensatory mechanism in patients with arterial obstructive disease. Here, we studied the role of lymphocytes in a murine model of hindlimb ischemia.

Methods and Results— Lymphocytes, detected with markers for NK1.1, CD3, and CD4, invaded the collateral vessel wall. Arteriogenesis was impaired in C57BL/6 mice depleted for Natural Killer (NK)-cells by anti-NK1.1 antibodies and in NK-cell–deficient transgenic mice. Arteriogenesis was, however, unaffected in J{alpha}281-knockout mice that lack NK1.1+ Natural Killer T (NKT)-cells, indicating that NK-cells, rather than NKT-cells, are involved in arteriogenesis. Furthermore, arteriogenesis was impaired in C57BL/6 mice depleted for CD4+ T-lymphocytes by anti-CD4 antibodies, and in major histocompatibility complex (MHC)-class-II–deficient mice that more selectively lack mature peripheral CD4+ T-lymphocytes. This impairment was even more profound in anti-NK1.1-treated MHC-class-II–deficient mice that lack both NK- and CD4+ T-lymphocytes. Finally, collateral growth was severely reduced in BALB/c as compared with C57BL/6 mice, 2 strains with different bias in immune responsiveness.

Conclusions— These data show that both NK-cells and CD4+ T-cells modulate arteriogenesis. Promoting lymphocyte activation may represent a promising method to treat ischemic disease.

The immune system is thought to play a crucial role in regulating collateral circulation (arteriogenesis). Here, we show that both natural killer cells and CD4+ T-cells modulate arteriogenesis. Promoting lymphocyte activation may represent a promising method to treat ischemic disease.


Key Words: peripheral vascular disease • angiogenesis • animal models of human disease


Related Article:

Prevention of Tissue Death by Killer Cells?: The Role of the Immune System in Arteriogenesis
Wolfgang Schaper
Arterioscler Thromb Vasc Biol 2007 27: 2273-2274. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
CirculationHome page
Y. Zouggari, H. Ait-Oufella, L. Waeckel, J. Vilar, C. Loinard, C. Cochain, A. Recalde, M. Duriez, B. I. Levy, E. Lutgens, et al.
Regulatory T Cells Modulate Postischemic Neovascularization
Circulation, October 6, 2009; 120(14): 1415 - 1425.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Distasi, J. Case, M. A. Ziegler, M. C. Dinauer, M. C. Yoder, L. S. Haneline, M. C. Dalsing, S. J. Miller, C. A. Labarrere, M. P. Murphy, et al.
Suppressed hindlimb perfusion in Rac2-/- and Nox2-/- mice does not result from impaired collateral growth
Am J Physiol Heart Circ Physiol, March 1, 2009; 296(3): H877 - H886.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. E. Toutain, L. Brouchet, I. Raymond-Letron, P. Vicendo, H. Berges, J. Favre, M.-J. Fouque, A. Krust, A.-M. Schmitt, P. Chambon, et al.
Prevention of Skin Flap Necrosis by Estradiol Involves Reperfusion of a Protected Vascular Network
Circ. Res., January 30, 2009; 104(2): 245 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. C. van Oostrom, O. van Oostrom, P. H. A. Quax, M. C. Verhaar, and I. E. Hoefer
Insights into mechanisms behind arteriogenesis: what does the future hold?
J. Leukoc. Biol., December 1, 2008; 84(6): 1379 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J.-S. Silvestre, Z. Mallat, A. Tedgui, and B. I. Levy
Post-ischaemic neovascularization and inflammation
Cardiovasc Res, May 1, 2008; 78(2): 242 - 249.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. T. van Beem, W. A. Noort, C. Voermans, M. Kleijer, A. ten Brinke, S. M. van Ham, C. E. van der Schoot, and J. J. Zwaginga
The Presence of Activated CD4+ T Cells Is Essential for the Formation of Colony-Forming Unit-Endothelial Cells by CD14+ Cells
J. Immunol., April 1, 2008; 180(7): 5141 - 5148.
[Abstract] [Full Text] [PDF]